Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
Blokirali ste korisnika/cu @kunhsingyu
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @kunhsingyu
-
Kun-Hsing Yu proslijedio/la je Tweet
A very warm welcome to our newest faculty addition, Kun-Hsing "Kun" Yu (
@kunhsingyu), assistant professor of biomedical informatics@harvardmed! P.S. Kun is currently seeking a postdoc in machine learning-enabled pathology—follow links for more info.https://dbmi.hms.harvard.edu/news/welcome-kun-hsing-yu …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Kun-Hsing Yu proslijedio/la je Tweet
Fragile X is not usually thought of as immune deregulation syndrome but a phenome-wide scan of ~5700 FXS patients show incr infections and underrepresented autoimmune diseasehttps://onlinelibrary.wiley.com/doi/abs/10.1111/ene.14146?af=R …
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Kun-Hsing Yu proslijedio/la je Tweet
Exciting post-doc: Work at the cutting edge of machine learning and pathology and oncology with
@HarvardDBMI faculty@kunhsingyuhttp://bit.ly/31teDQqHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Want to transform pathology research and practice through machine learning? My group
@HarvardDBMI is hiring a postdoc with experience in machine learning! (https://dbmi.hms.harvard.edu/careers/postdoctoral-fellows/yu-lab …).Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Kun-Hsing Yu proslijedio/la je Tweet
Come hear
@geochurch Matthew de Silva@notableLabs Ken Ehlert@UHC Timothy Yu@BostonChildrens on our panel on Hyperindividualized Therapy at our 5th Annual Patient-driven Precision Medicine Conference June 18th Registration:https://buff.ly/2GoC9W3Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Kun-Hsing Yu proslijedio/la je Tweet
Wonderful turnout to David Reich’s talk at the Omenn lecture. In each person a multitude, says our DNA.pic.twitter.com/3JY2YAKw8E – mjesto: Harvard Medical School Gordon Hall
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Kun-Hsing Yu proslijedio/la je Tweet
The most powerful partnership of 21st century medicine: data science, doctors and patientshttp://bit.ly/2PyIkxW
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Kun-Hsing Yu proslijedio/la je Tweet
Friday, November 16, 1-2pm Inaugural Gilbert S. Omenn Lecture We are pleased to welcome speaker David Reich, PhD Professor of Genetics
@harvardmed & HHMI Investigator "Ancient DNA, Biology, and Disease" Learn more and add it to your own calendar via https://dbmi.hms.harvard.edu/events?trumbaEmbed=view%3Devent%26eventid%3D130049648 …pic.twitter.com/GplhYGnJfL
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Kun-Hsing Yu proslijedio/la je Tweet
Toward Precision Oncology: Quantitative Pathology, Multi-Omics, and Artificial Intelligence today with Dr. Kun-Hsing Yu http://bit.ly/2kGzVpm
@HarvardDBMI#AI#PathologyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Kun-Hsing Yu proslijedio/la je Tweet
How will
#AI transform the practice of medicine?@HarvardDBMI postdoctoral fellow Kun-Hsing Yu led a@harvardmed#TalksAt12 exploring future impacts on health care. Watch video:https://buff.ly/2NUoVGmHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Kun-Hsing Yu proslijedio/la je Tweet
Impressions from the final project poster session of the
@HarvardDBMI#deeplearning course taught by@AndrewLBeam and@kunhsingyu: https://hms-dbmi.github.io/BMI_707 . Our students did an amazing job pulling off some impressive projects in very little time!pic.twitter.com/z0Naq5DoZf – mjesto: Countway Library of Medicine
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.